American Portfolios Advisors Titan Pharmaceuticals Inc Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Titan Pharmaceuticals Inc stock. As of the latest transaction made, American Portfolios Advisors holds 23 shares of TTNP stock, worth $79. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23
Holding current value
$79
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$0.53 - $22.6 $12 - $519
23 New
23 $25,000

Others Institutions Holding TTNP

# of Institutions
1
Shares Held
23
Call Options Held
0
Put Options Held
0
View Full List

About TITAN PHARMACEUTICALS INC

TTNP Quotes by TradingView
  • Ticker TTNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,629,200
  • Market Cap $50.6M
  • Description
  • Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...
More about TTNP
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email